WDNA Holdings
WisdomTree BioRevolution Fund
1W: -1.6%
1M: +0.3%
3M: +10.9%
YTD: +39.2%
1Y: +44.5%
3Y: +58.0%
5Y: -9.7%
$23.55
-0.08 (-0.35%)
Weekly Expected Move ±4.0%
$22
$23
$24
$24
$25
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$3M
Holdings79
Top 10 Wt41.0%
Beta1.26
% Profitable44%
Coverage100%
Portfolio Valuation
P/E39.6
P/B8.3
P/S6.8
EV/EBITDA25.6
P/FCF37.0
PEG4.36
Profitability & Returns
Gross Margin64.3%
Net Margin13.1%
ROE16.5%
ROA6.7%
ROIC14.3%
Div Yield0.57%
Leverage & Liquidity
Debt/Equity0.81
Debt/Assets0.32
Net Debt/EBITDA1.5x
Interest Cov9.6x
Current Ratio1.40
Quick Ratio1.08
Growth (YoY)
Revenue+9.5%
Net Income+1.0%
EPS+5.1%
FCF+17.2%
EBITDA+8.2%
Rev CAGR 3Y+31.4%
Quality Scores
Piotroski F4.4
Altman Z12.04
IS Quality56.0
IS Overall46.8
IS Value37.9
Median P/E-2.7
Sector Breakdown
4 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 69 | 90.9% | 2.6 |
| Basic Materials | 7 | 5.4% | -37.9 |
| Consumer Defensive | 3 | 3.4% | 22.8 |
| Other | 7 | 0.2% | — |
Smart Money Overlap
1 holdings with signals| Symbol | Company | Weight % | Signals | Badge | Insider Buys | Congress | Since Signal |
|---|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 1.40% | 4 | Bullish | 3 | 2 | +5.6% |
Showing 50 of 86 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Moderna Inc | MRNA | 10.20% | $486,492 | 2,466 | -23.8 | $75.4B | Healthcare |
| 2 | Twist Bioscience Corp | TWST | 9.06% | $431,938 | 2,405 | -85.0 | $11.7B | Healthcare |
| 3 | 10X Genomics Inc-Class A | TXG | 3.65% | $173,814 | 1,964 | -158.5 | $11.9B | Healthcare |
| 4 | Eli Lilly & Co | LLY | 3.50% | $167,054 | 141 | 38.2 | $1.1T | Healthcare |
| 5 | Natera Inc | NTRA | 3.09% | $147,414 | 358 | -301.7 | $58.8B | Healthcare |
| 6 | Tempus Ai Inc | TEM | 2.92% | $139,446 | 1,639 | -53.6 | $13.4B | Healthcare |
| 7 | Johnson & Johnson | JNJ | 2.76% | $131,624 | 484 | 29.6 | $617.0B | Healthcare |
| 8 | Immunome Inc | IMNM | 2.02% | $96,129 | 4,434 | -8.2 | $2.0B | Healthcare |
| 9 | United Therapeutics Corp | UTHR | 1.89% | $90,310 | 186 | 17.9 | $23.0B | Healthcare |
| 10 | Darling Ingredients Inc | DAR | 1.88% | $89,491 | 1,477 | 16.7 | $10.0B | Consumer Defensive |
| 11 | Iovance Biotherapeutics Inc | IOVA | 1.78% | $84,854 | 7,721 | -20.3 | $6.3B | Healthcare |
| 12 | Thermo Fisher Scientific Inc | TMO | 1.76% | $84,146 | 124 | 35.2 | $242.1B | Healthcare |
| 13 | Revolution Medicines Inc | RVMD | 1.60% | $76,056 | 377 | -23.3 | $43.9B | Healthcare |
| 14 | Gilead Sciences Inc | GILD | 1.59% | $75,953 | 499 | -55.7 | $179.5B | Healthcare |
| 15 | Corteva Inc | CTVA | 1.59% | $75,952 | 977 | 7.9 | $8.0B | Basic Materials |
| 16 | Roivant Sciences Ltd | ROIV | 1.58% | $75,328 | 2,037 | -94.0 | $25.8B | Healthcare |
| 17 | Amgen Inc | AMGN | 1.57% | $74,845 | 179 | 24.8 | $217.5B | Healthcare |
| 18 | Krystal Biotech Inc | KRYS | 1.55% | $73,821 | 219 | 39.0 | $9.5B | Healthcare |
| 19 | Crispr Therapeutics Ag | CRSP | 1.54% | $73,400 | 1,357 | -11.6 | $5.3B | Healthcare |
| 20 | Stoke Therapeutics Inc | STOK | 1.43% | $68,187 | 2,674 | -7.6 | $1.7B | Healthcare |
| 21 | Pfizer Inc | PFE | 1.40% | $66,803 | 2,326 | 36.7 | $158.4B | Healthcare |
| 22 | Astrazeneca Plc | AZN.L | 1.40% | $66,792 | 402 | 23.4 | $184.1B | Healthcare |
| 23 | Bayer AG | BAYN.DE | 1.39% | $66,158 | 1,146 | -25.5 | $44.2B | Healthcare |
| 24 | Bunge Global Sa | BG | 1.34% | $63,909 | 586 | 20.7 | $20.5B | Consumer Defensive |
| 25 | Beam Therapeutics Inc | BEAM | 1.29% | $61,544 | 2,540 | -29.9 | $2.5B | Healthcare |
| 26 | Vertex Pharmaceuticals Inc | VRTX | 1.27% | $60,682 | 115 | 29.1 | $128.1B | Healthcare |
| 27 | Novozymes A/S | NZYM-B.CO | 1.24% | $59,295 | 915 | 36.4 | $184.5B | Basic Materials |
| 28 | Agios Pharmaceuticals Inc | AGIO | 1.24% | $59,020 | 1,766 | -4.5 | $1.9B | Healthcare |
| 29 | ABSCI Corp | ABSI | 1.22% | $58,231 | 6,136 | -13.8 | $1.9B | Healthcare |
| 30 | Structure Therapeutics Inc | GPCR | 1.21% | $57,542 | 1,641 | -9.1 | $1.6B | Healthcare |
| 31 | Biohaven Ltd | BHVN | 1.07% | $51,182 | 3,857 | -2.8 | $1.9B | Healthcare |
| 32 | Novartis AG | NOVN.SW | 1.06% | $50,480 | 346 | 21.3 | $221.1B | Healthcare |
| 33 | Arcturus Therapeutics Hlgs | ARCT | 1.04% | $49,728 | 3,439 | -3.9 | $370M | Healthcare |
| 34 | Arrowhead Pharmaceuticals Inc | ARWR | 1.04% | $49,488 | 756 | -28.7 | $9.0B | Healthcare |
| 35 | Protagonist Therapeutics Inc | PTGX | 1.03% | $49,142 | 345 | 115.0 | $9.0B | Healthcare |
| 36 | Veracyte Inc | VCYT | 0.98% | $46,858 | 1,036 | 31.8 | $3.7B | Healthcare |
| 37 | Exelixis Inc | EXEL | 0.98% | $46,579 | 798 | 17.7 | $14.7B | Healthcare |
| 38 | Isis Pharmaceuticals Inc | IONS | 0.94% | $44,613 | 979 | -12.6 | $7.2B | Healthcare |
| 39 | Uniqure NV | QURE | 0.91% | $43,569 | 1,114 | -5.8 | $1.6B | Healthcare |
| 40 | Repligen Corp | RGEN | 0.90% | $43,088 | 222 | 245.5 | $10.3B | Healthcare |
| 41 | Argenx Se - Adr | ARGX | 0.84% | $39,862 | 41 | 33.3 | $57.2B | Healthcare |
| 42 | Biontech Se-ADR | BNTX | 0.82% | $39,236 | 396 | -12.7 | $24.3B | Healthcare |
| 43 | Halozyme Therapeutics Inc | HALO | 0.81% | $38,495 | 341 | 31.2 | $13.0B | Healthcare |
| 44 | Danaher Corp | DHR | 0.78% | $37,055 | 163 | 37.9 | $150.5B | Healthcare |
| 45 | Cg Oncology Inc | CGON | 0.77% | $36,545 | 525 | -25.0 | $5.9B | Healthcare |
| 46 | Biogen Idec Inc | BIIB | 0.76% | $36,133 | 158 | 38.7 | $32.5B | Healthcare |
| 47 | Cullinan Therapeutics Inc | CGEM | 0.75% | $35,581 | 2,380 | -4.6 | $953M | Healthcare |
| 48 | Celldex Therapeutics Inc | CLDX | 0.71% | $33,946 | 1,078 | -7.3 | $2.1B | Healthcare |
| 49 | Illumina Inc | ILMN | 0.71% | $33,716 | 124 | 50.5 | $41.3B | Healthcare |
| 50 | Merck & Co Inc/NJ | MRK | 0.70% | $33,158 | 223 | 114.5 | $356.4B | Healthcare |